Warner Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Warner Financial’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$628K	Buy	5,745 +47	+0.8%	+$4.87K	0.18%	79
2026 Q1	$592K	Hold	5,698	–	–	0.2%	76
2025 Q4	$588K	Buy	5,698 +1,030	+22%	+$100K	0.2%	73
2025 Q3	$422K	Buy	4,668 +32	+0.7%	+$2.8K	0.16%	82
2025 Q2	$408K	Buy	4,636 +28	+0.6%	+$2.43K	0.17%	82
2025 Q1	$420K	Hold	4,608	–	–	0.19%	79
2024 Q4	$398K	Buy	4,608 +42	+0.9%	+$3.8K	0.17%	84
2024 Q3	$434K	Buy	4,566 +18	+0.4%	+$1.71K	0.19%	85
2024 Q2	$416K	Buy	4,548 +27	+0.6%	+$2.41K	0.2%	81
2024 Q1	$410K	Buy	4,521 +17	+0.4%	+$1.49K	0.21%	81
2023 Q4	$367K	Buy	4,504 +19	+0.4%	+$1.49K	0.21%	78
2023 Q3	$358K	Buy	4,485 +22	+0.5%	+$1.77K	0.24%	70
2023 Q2	$352K	Buy	4,463 +37	+0.8%	+$2.9K	0.23%	75
2023 Q1	$344K	Buy	4,426 +793	+22%	+$61.1K	0.24%	74
2022 Q4	$282K	Buy	+3,633	New	+$268K	0.21%	74

Other funds holding PPH

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

RBC

Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return

WWM

WT Wealth Management Scottsdale, Arizona $361M AUM 23.03% 1-Year Est. Return

Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return

AWMT

AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

CWRP

Cassady Wealth & Retirement Planning Henderson, Nevada $215M AUM

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AWA

ARQ Wealth Advisors Scottsdale, Arizona $807M AUM 19.58% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Warner Financial's PPH Position: Q2 2026 in Review

Warner Financial increased its VanEck Pharmaceutical ETF (PPH) stake by 0.82% in Q2 2026, buying an estimated $4.87K and bringing the position to 5,745 shares worth $628K. The position accounts for 0.18% of the portfolio, ranked #79.

Warner Financial first reported a position in PPH in Q4 2022 and has held it in 15 quarters since. 47 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Warner Financial held 5,745 shares of VanEck Pharmaceutical ETF worth $628K as of Q2 2026.
Warner Financial bought 47 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $4.87K.
VanEck Pharmaceutical ETF made up 0.18% of Warner Financial's portfolio in Q2 2026, its #79 holding.
Warner Financial first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 15 quarters since.
47 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Warner Financial's 13F filing for Q2 2026, filed 9 Jul 2026.